Scientists test 'Off-the-Shelf' cell therapy for tough leukemia
NCT ID NCT07256353
Summary
This early-stage study is testing a new cell therapy for adults with a type of blood cancer called B-cell acute lymphoblastic leukemia (B-ALL). The therapy uses immune cells (CAR-T cells) made from donated umbilical cord blood, not the patient's own cells. Researchers will give the therapy to up to 50 participants to find the safest and most effective dose and to see how well it controls the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA, ADULT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The General Hospital of Western Theater Command
Chengdu, Sichuan, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.